Astragalus to ease symptoms during lymphoma chemotherapy
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests whether a herbal supplement called astragalus can help reduce side effects from chemotherapy in people with high-grade lymphoma. If you are starting your first chemo treatment, this study might be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with high-grade lymphoma
- About to start first chemotherapy treatment
- Able to fill out a short questionnaire once a month
- No past chemotherapy
- No serious liver or kidney problems, active autoimmune disease, or pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how integrative medicine (such as nutrition, mind-body practices, or supplements) might help people recover and improve well-being after finishing lymphoma treatment. It is for patients who are in remission for less than one year.
This study tests whether a personalized exercise program during chemotherapy can help people with lymphoma feel stronger and have fewer side effects. You would take part in supervised exercise sessions twice a week for 20 weeks.
This study looks at whether taking short, frequent breaks from sitting can help people with lymphoma who are starting chemotherapy feel better and have fewer side effects. If you join, you'll get a wearable activity tracker and text reminders to stand up and move gently throughout your day.
This study tests whether a heart-protective medication called sotagliflozin can prevent heart damage caused by strong chemotherapy drugs used to treat newly diagnosed lymphoma. You would take this medication during and after your cancer treatment.
This trial tests if a heart-protecting drug (dexrazoxane) can prevent heart damage in people getting chemotherapy for certain types of large B-cell lymphoma. It is for patients who already have heart risk factors or a history of heart failure.
This early study tests whether replacing magnesium—either by diet or a topical (skin) supplement—can improve safety or other health measures in people with lymphoma. It focuses on people who have a slightly low magnesium level and checks blood magnesium repeatedly during the study.
Hear when a new High-grade Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.